FDA

Scholars examine the implications of using patient-reported data in health care practice and regulation.

Marion Nestle discusses changes to agencies that would create a safer food environment.

Political pressure and wary regulators shaped FDA’s mifepristone approval in 2000.

Scholar proposes an increased focus on children’s health in food, drug, and cosmetic regulation.

Scholars debate ways to improve FDA’s accelerated approval mechanism.

Scholars argue that data-sharing lessons from clinical trials can apply to social media.

Scholar calls for regulators to correct the dangers of inadequate cosmetics regulations for women of color.

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

The Loper Bright decision leaves hundreds of pivotal health care regulations subject to litigation.

Scholar calls for Congress to empower regulators to limit exposure to cancer-causing chemicals.

FDA approves first over-the-counter continuous glucose monitor for U.S. patients.

Contaminated agricultural water is a well-known root cause of foodborne illness that regulators have struggled to address.